dealase

Biotech · Public company · Rancho Cucamonga, CA, US

Amphastar Pharmaceuticals, Inc.

Ticker AMPH · SEC CIK 0001297184

Track this companyFree. Adds Amphastar Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed

Pipeline5

Clinical trials3

  • Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy VolunteersPHASE2_PHASE3 · COMPLETED · started Apr 6, 2026ClinicalTrials.gov NCT07560150 · fetched Nov 12, 2026
  • Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy VolunteersPHASE2_PHASE3 · COMPLETED · started Aug 22, 2022ClinicalTrials.gov NCT05539872 · fetched Nov 12, 2026
  • Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy IndividualsPHASE4 · COMPLETED · started Dec 9, 2019ClinicalTrials.gov NCT04207840 · fetched Nov 12, 2026

SEC filings12